Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$68.26 - $76.19 $498,639 - $556,567
7,305 New
7,305 $556,000
Q1 2023

May 12, 2023

BUY
$51.63 - $56.93 $303,584 - $334,748
5,880 New
5,880 $334,000
Q4 2021

Feb 11, 2022

SELL
$59.5 - $67.25 $185,521 - $209,685
-3,118 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$60.19 - $75.29 $187,672 - $234,754
3,118 New
3,118 $203,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.35B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.